Company Filing History:
2 out of 9 
1 out of 113 
1 out of 989 
Years Active: 2024-2025
Title: Unveiling the Innovative Work of Inventor Hitoshi Endou
Introduction: Hitoshi Endou, a talented inventor based in Yokohama, Japan, has made significant contributions in the field of cancer therapy through his groundbreaking patent. His innovative methods have paved the way for more effective and personalized treatment strategies in the realm of oncology.
Latest Patents: Hitoshi Endou's most recent patent encompasses a "Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy." This patent introduces novel biomarkers to predict patient responses to specific antibody therapies and evaluate cancer malignancy levels accurately.
Career Highlights: Throughout his career, Hitoshi Endou has displayed exceptional expertise and dedication to advancing medical science. He has notably worked with esteemed organizations such as J-Pharma Co., Ltd. and the National University Corporation Gunma University, where his research and inventions have had a profound impact on the field of oncology.
Collaborations: Hitoshi Endou has had the privilege of collaborating with accomplished professionals in the industry, including Goshi Ishihara and Kyoichi Kaira. Together, they have synergized their skills and knowledge to drive innovation and bring about positive changes in cancer treatment methodologies.
Conclusion: Hitoshi Endou's unwavering commitment to pioneering cutting-edge solutions in cancer therapy is truly commendable. His inventive spirit, coupled with his collaborative efforts, continues to shape the landscape of medical innovations. We eagerly anticipate further breakthroughs from this visionary inventor in the future.